This week we highlight how big pharma is grappling with potential challenges surrounding drug pricing and the Inflation Reduction Act of 2022. We also look at Labcorp’s proposed spinoff of its clinical development business, progress toward the $100 genome, the return on investment of decentralized ... READ MORE >
5 things to know in life sciences: Week of July 25, 2022
This week we highlight a new enhanced COVID-19 vaccine trial and the spin out of another major health care business. We also look at a Food and Drug Administration clearance for the smallest blood clot removal device and a company that raised $192 million based on a heart-attack-predicting software ... READ MORE >
5 things to know in life sciences: Week of July 18, 2022
This week we highlight continued investment in driving more diversity and better representation in clinical trials. We also look at the impact of decentralized technology on trial enrollments, a major whistleblower settlement and the approval of a COVID-19 vaccine manufactured using traditional methods. ... READ MORE >
5 things to know in life sciences: Week of July 11, 2022
This week we highlight innovative treatments for heart disease and depression. We also look at a decision by the Food and Drug Administration to allow pharmacists to prescribe a COVID-19 drug, as well as the use of artificial intelligence in the fight against ALS. Finally, we touch on Vertex’s acquisition ... READ MORE >
5 things to know in life sciences: Week of June 27, 2022
This week we highlight actions by a U.S. Food and Drug Administration advisory panel deciding on what COVID-19 boosters should contain for this fall. The panel voted overwhelmingly to include updates for the omicron variant, setting up the potential that COVID-19 vaccines will be managed like the flu with ... READ MORE >
5 things to know in life sciences: Week of June 20, 2022
This week we highlight a new app that assists patients with Parkinson’s disease and a European trade organization that seeks help to address inflation concerns. In addition, a new contact lens designed to combat eye fatigue from digital devices receives regulatory approval and researchers identify a ... READ MORE >
5 things to know in life sciences: Week of June 13, 2022
Diagnosing some disorders in children present unique challenges. Now, companies are looking at using artificial intelligence to uncover subtle tools to help. We also look at a new report on diversity in the biotech industry, research into long COVID-19, and Food and Drug Administration site inspections. ... READ MORE >
5 things to know in life sciences: Week of June 6, 2022
Management of diabetes care has improved dramatically since the introduction of insulin pumps and continuous glucose monitoring. Now, companies are hopeful that an “artificial pancreas” is on the horizon, which would substantially improve the standard of care for this common disease. We also look at 3D ... READ MORE >
5 things to know in life sciences: Week of May 23, 2022
This week we highlight an international collaboration for an innovative under-the-skin insulin delivery device, a focus on improving diversity for clinical trials and a promising COVID-19 vaccine for children under 5. Finally, at-home testing for sexually transmitted diseases is coming, and the University ... READ MORE >
5 things to know in life sciences: Week of May 16, 2022
This week we highlight new demand for smallpox vaccines driven by a monkeypox outbreak, the continuing need to improve representation in clinical trials, controlling machines with just your mind, and the lack of combination trials involving a COVID-19 antiviral. Finally, we look at new “smart” contacts ... READ MORE >